| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/07/1997 | US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI) |
| 01/07/1997 | US5591632 Recombinant BCG |
| 01/07/1997 | US5591631 Anthrax toxin fusion proteins, nucleic acid encoding same |
| 01/07/1997 | US5591630 Monoclonal antibodies that bind interleukin-15 receptors |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591626 Central nervous systems and genetic engineering |
| 01/07/1997 | US5591625 Can differentiate into different connective tissue types; genetic engineering |
| 01/07/1997 | US5591624 Retroviral packaging cell lines |
| 01/07/1997 | US5591623 Oligonucleotide modulation of cell adhesion |
| 01/07/1997 | US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity |
| 01/07/1997 | US5591618 G protein-coupled receptor kinase GRK6 |
| 01/07/1997 | US5591616 Method for transforming monocotyledons |
| 01/07/1997 | US5591610 Dephosphorylation by ester interchange; genetic engineering |
| 01/07/1997 | US5591609 Methods for the isothermal amplification of nucleic acid molecules |
| 01/07/1997 | US5591605 Genetic engineering of dicot plant cells |
| 01/07/1997 | US5591604 Recombinant antibodies at the surface of E. coli |
| 01/07/1997 | US5591602 Nucleic acid encoding opioid receptor |
| 01/07/1997 | US5591601 DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system |
| 01/07/1997 | US5591600 Antisense inhibitors of the human immunodeficiency virus |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591592 Method for detection of fibronectin receptor ligands |
| 01/07/1997 | US5591590 Neuronal nicotinic acetylcholine receptor assay |
| 01/07/1997 | US5591586 Hybridization mapping of nucleic acids |
| 01/07/1997 | US5591583 Human restrictin and nucleic acid sequences |
| 01/07/1997 | US5591580 Method, test element and test kit for semi-quantitative detection of target nucleic acid |
| 01/07/1997 | US5591579 Indicator cell line for detecting RNA viruses and method therefor |
| 01/07/1997 | US5591578 Nucleic acid mediated electron transfer |
| 01/07/1997 | US5591577 Mobile genetic element originated from brevibacterium strain |
| 01/07/1997 | US5591576 Sterol Δ14 reductase screen |
| 01/07/1997 | US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 |
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
| 01/07/1997 | US5591439 Treatment of herpes infections |
| 01/07/1997 | US5591427 Modulating proliferation, differentiation, or activation of cells |
| 01/07/1997 | CA2115136C Factor xiii compositions |
| 01/07/1997 | CA1338829C Superior mammalian expression system |
| 01/07/1997 | CA1338827C Fruit-specific transcriptional factors |
| 01/03/1997 | WO1997000330A2 Process for the transcriptionless amplification of nucleic acids |
| 01/03/1997 | WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/03/1997 | WO1997000325A1 Bacillus strain and sporulation assay method |
| 01/03/1997 | WO1997000324A1 Gene encoding alkaline liquefying alpha-amylase |
| 01/03/1997 | WO1997000323A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 01/03/1997 | WO1997000322A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | WO1997000321A1 Immune response modulators and uses therefor |
| 01/03/1997 | WO1997000320A1 Modified polypeptide, dna encoding the same, transformant, and medicinal composition containing the polypeptide |
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | WO1997000316A1 A process for producing trypsin (trypsinogen) |
| 01/03/1997 | WO1997000269A1 New family of linear antimicrobial peptides from hagfish intestine |
| 01/03/1997 | WO1997000266A1 Novel enhancer sequences for late t cell expressed genes |
| 01/03/1997 | WO1997000241A1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000081A1 A method for inhibiting bacteremia and bacterial dissemination |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | WO1996038587A3 Method for detecting heat-resistant micro-organisms capable of contaminating certain food products |
| 01/03/1997 | WO1996037621A3 Multimeric proteins |
| 01/03/1997 | WO1996035717A3 Soluble, cleavable substrates of the hepatitis c virus protease |
| 01/03/1997 | WO1996034981A3 METHOD FOR THE SPECIFIC COUPLING OF THE CAP OF THE EXTREMITY 5' OF A FRAGMENT mRNA AND PREPARATION OF mRNA AND COMPLETE cDNA |
| 01/03/1997 | WO1996034965A3 Chimeric mcp and daf proteins with cell surface localizing domain |
| 01/03/1997 | CA2224976A1 New family of linear antimicrobial peptides from hagfish intestine |
| 01/03/1997 | CA2224723A1 Novel enhancer sequences for late t cell expressed genes |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | CA2224645A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224566A1 New cationic and polycationic amphiphiles, reagents containing them and their use |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/02/1997 | EP0751226A2 Process for amplifying nucleic acid sequences |
| 01/02/1997 | EP0751222A2 Gene encoding endoglycoceramidase |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
| 01/02/1997 | EP0751219A1 Platelet aggregation inhibitors |
| 01/02/1997 | EP0751218A2 Sucrose-metabolism mutants |
| 01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
| 01/02/1997 | EP0750681A1 Assays for immunosuppressants |
| 01/02/1997 | EP0750680A1 Electrochemical denaturation of double-stranded nucleic acid |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750677A1 Process for treating eucaryotic cells |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750672A1 Dna sequences for matrix metalloproteases, their production and use |
| 01/02/1997 | EP0750671A1 Transgenic animals producing oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750670A1 Compositions useful in controlling marek's disease |
| 01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750667A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750665A1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
| 01/02/1997 | EP0750663A1 Apparatus and method for efficient incorporation of molecules into cells |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750634A1 Enhanced secretion of polypeptides |
| 01/02/1997 | EP0750630A1 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750627A1 Transgenic animal assay system for anti-cholinesterase substances |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |